Introduction The underlying causes of supply-side and demand-side challenges in immunisation are poorly understood, leading to symptomatic solutions. This study engaged stakeholders to develop ...

Revenue and Adjusted EBITDA results delivered in line with stated full-year targetsFull-year cost savings exceeded previously communicated targets Highlights: Revenues of $660.5 million for the fourth ...

Gunnison Copper is pleased to announce the results of an updated NI 43-101 Preliminary Economic Assessment on its 100%-owned Gunnison Copper Project. The PEA supersedes the previous PEA on the ...

Braking distances of heavy-duty vehicles tested in winter conditions in Pudasjärvi, Northern Finland – measurements and weather services enhance ...

Gunnison Copper Corp. is pleased to announce the results of an updated NI 43-101 Preliminary Economic Assessment on its 100%-owned Gunnison Copper Project in the Cochise Mining District, Arizona, ...

PRESS RELEASE Courbevoie, France - February 25, 2026 Sector-leading organic revenue growth of 6.5% in FY 2025 Strong margin improvement to 16.3% in FY 2025 Positive growth outlook with continued margi ...

There is a gap between the evaluation of injury prevention programmes in controlled trials and their use in real-world ...

NHS England » Chief Allied Health Professions Officer Awards 2026 – instruction pack for submitting a nomination ...

Researchers at Washington University School of Medicine in St. Louis have developed a method to predict when someone is likely to develop symptoms of ...

If your workflow feels stuck, these underrated apps might be the upgrade you did not know you needed, across every device you use daily.

Background A more nuanced understanding of behavioural responses to incentives over time, particularly after they are removed, could guide more effective interventions. In this study, we build on the ...

Introduction Dyspnoea is an existentially burdensome symptom in patients with advanced and progressive diseases such as cancer, chronic obstructive pulmonary disease (COPD) and advanced heart failure.